B. Bisig

Discipline

Economies et finances (4) Sociologie (1) Psychologie (1)

Type de document

Articles (28) Recensions (7)

Co-auteur

Date

Source

Mot-clé

Human beings (14) Lymphomas (13) Cases (10) Patients (10) Cases (10) Patients (10) Tumors (8) Cancer (8) pathologie (7) mutation (7) Pathology (7) Mutation (7) tissu (corporel) (6) classification (6) Diagnosis (6) Case (6) Grammar, Comparative and general--Case (6) Diagnosis (6) Classification (6) Case (6) Older people (6) Classification (6) Classification (6) Analysis (6) morphologie (5) analyse (5) Morphology (5) Treatment (5) Cancer (5) Morphology (5)

Documents écrit par B. Bisig (28) | parle de B. Bisig (0)

Angioimmunoblastic T-cell lymphoma and Kaposi sarcoma: A fortuitous collision?
E. Poullot et al.
Pulmonary squamous cell carcinoma and lymphoepithelial carcinoma - morphology, molecular characteristics and differential diagnosis.
S. Berezowska et al.
Deep and lasting response and acquired resistance to BRAFV600E targeting in a low-grade ovarian cancer patient.
S. Anchisi et al. (31 déc. 2023)
Pathobiology of nodal peripheral T-cell lymphomas: current understanding and future directions.
B. Bisig et al. (1 déc. 2023)
Was gibt es Neues bei der Klassifikation der peripheren T-Zell-Lymphomen? [What is new in the classification of peripheral T cell lymphomas?]
L. de Leval et al.
Real-world EGFR testing practices for non-small-cell lung cancer by thoracic pathology laboratories across Europe.
P. Hofman et al.
MarrowQuant 2.0: A Digital Pathology Workflow Assisting Bone Marrow Evaluation in Experimental and Clinical Hematology.
R. Sarkis et al.
Response and Resistance to Trametinib in MAP2K1-Mutant Triple-Negative Melanoma.
F.S. Krebs et al. (24 févr. 2023)
Monomorphic epitheliotropic intestinal T-cell lymphoma comprises morphologic and genomic heterogeneity impacting outcome.
L. Veloza et al. (1 janv. 2023)
EBV-positive large B-cell lymphoma with an unusual intravascular presentation and associated haemophagocytic syndrome in an HIV-positive patient: report of a case expanding the spectrum of EBV-positive immunodeficiency-associated lymphoproliferative disorders.
L. Veloza et al.
Isolated skin infiltration by a blastic plasmacytoid dendritic cell neoplasm.
G. Stalder et al.
Postmortem Cardiopulmonary Pathology in Patients with COVID-19 Infection: Single-Center Report of 12 Autopsies from Lausanne, Switzerland.
K. Ioannidou et al. (28 juil. 2021)
Carcinome anaplasique de la thyroïde : nouvelles approches thérapeutiques [Anaplastic thyroid carcinoma : new therapeutic approaches]
A. Stamatiou et al. (19 mai 2021)
Recent advances upper gastrointestinal lymphomas: molecular updates and diagnostic implications.
P.G. Foukas et al.
Trametinib Induces the Stabilization of a Dual GNAQ p.Gly48Leu- and FGFR4 p.Cys172Gly-Mutated Uveal Melanoma. The Role of Molecular Modelling in Personalized Oncology.
F.S. Krebs et al. (28 oct. 2020)
MarrowQuant Across Aging and Aplasia: A Digital Pathology Workflow for Quantification of Bone Marrow Compartments in Histological Sections.
J. Tratwal et al. (24 sept. 2020)
Meningeal Relapse of Nodular Lymphocyte Predominant Hodgkin Lymphoma Transformed to T-Cell/Histiocyte-Rich Large B-Cell Lymphoma: A Case Report.
P. Salvioni Chiabotti et al. (14 sept. 2020)
Defining signatures of peripheral T-cell lymphoma with a targeted 20-marker gene expression profiling assay.
A. Abdel-Sater et al.
Acinar cell carcinoma of the pancreas with thyroid-like follicular features: first description of a new diagnostic challenging subtype.
C. Saglietti et al.
Dual JAK1 and STAT3 mutations in a breast implant-associated anaplastic large cell lymphoma.
A. Letourneau et al.
La biopsie liquide, une nouvelle opportunité pour l’oncologie personnalisée [Liquid biopsy, a new opportunity for personalized oncology]
C. Astaras et al. (16 mai 2018)
The Bethesda System for Reporting Thyroid Cytopathology Explained for Practitioners: Frequently Asked Questions.
M. Bongiovanni et al.
Comment on "MEK inhibition with trametinib and tyrosine kinase inhibition with imatinib in multifocal histiocytic sarcoma".
S. Voruz et al.
Du neuf dans l’oncogenèse moléculaire des lymphomes : rôle du gène SETD2 dans les lymphomes T de l’intestin [Molecular oncogenesis of lymphomas: role of the SETD2 gene in intestinal T-cell lymphomas]
D. Vallois et al.
Continuous quantification of HER2 expression by microfluidic precision immunofluorescence estimates HER2 gene amplification in breast cancer.
D.G. Dupouy et al. (9 févr. 2016)

next